Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
Genetics ; 133(2): 279-90, 1993 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8382174

RESUMEN

P transposon induced modifier mutations of position-effect variegation (PEV) were isolated with the help of hybrid dysgenic crosses (pi 2 strain) and after transposition of the mutator elements pUChsneory+ and P[lArB]. Enhancer mutations were found with a ten times higher frequency than suppressors. The 19 pUChsneory(+)- and 15 P[lArB]-induced enhancer mutations can be used for cloning of genomic sequences at the insertion sites of the mutator elements via plasmid rescue. Together with a large sample of X-ray-induced (48) and spontaneous (93) enhancer mutations a basic genetic analysis of this group of modifier genes was performed. On the basis of complementation and mapping data we estimate the number of enhancer genes at about 30 in the third chromosome and between 50 and 60 for the whole autosome complement. Therefore, enhancer of PEV loci are found in the Drosophila genome as frequently as suppressor genes. Many of the enhancer mutations display paternal effects consistent with the hypothesis that some of these mutations can induce genomic imprinting. First studies on the developmentally regulated gene expression of PEV enhancer genes were performed by beta-galactosidase staining in P[lArB] induced mutations.


Asunto(s)
Elementos Transponibles de ADN/genética , Drosophila melanogaster/genética , Elementos de Facilitación Genéticos , Genes Supresores , Animales , Cruzamientos Genéticos , Elementos de Facilitación Genéticos/efectos de la radiación , Femenino , Prueba de Complementación Genética , Hibridación Genética/genética , Masculino , Mutagénesis , Ovario/química , Monoéster Fosfórico Hidrolasas/genética , Proteínas Recombinantes de Fusión/biosíntesis , Proteínas Recombinantes de Fusión/genética , Testículo/química , Dedos de Zinc/genética
2.
Pharmazie ; 37(12): 827-8, 1982 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-6298840

RESUMEN

The synthesis of a cardenolide glycoside with a furanoide sugar component, digitoxigenin-3 beta-O-alpha-L-arabinofuranoside (4), is described for the first time. 4 was prepared by the reaction of digitoxigenin with 2,3,5-tri-O-benzoyl-alpha-L-arabinofuranosylchloride and Fétizon-reagent in benzene/dioxan followed by debenzoylation with ammonia in dry methanol. Compound 4 is cleaved by alpha-L-arabinofuranosidase (Aspergillus niger K1) into digitoxigenin and L-arabinose. Hydrolytic stability against methanolic HCl (0.1 mol/l) is relatively high. 4 X 10(-8) mol/l 4 gives a 50% inhibition of the Na,K-ATPase (pig heart muscle) and is 2.5 times more active at this receptor than the aglycon digitoxigenin.


Asunto(s)
Glicósidos Cardíacos/síntesis química , Digitoxigenina/análogos & derivados , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Animales , Glicósidos Cardíacos/farmacología , Fenómenos Químicos , Química , Digitoxigenina/síntesis química , Digitoxigenina/farmacología , Estabilidad de Medicamentos , Hidrólisis , Miocardio/enzimología , Porcinos
3.
Pharmazie ; 43(12): 834-7, 1988 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-3247375

RESUMEN

The synthesis of 5-bromosalicyl-4'-chloroanilide-O-beta-D-xylopyranoside and other glycosides of 5-bromosalicyl-4'-chloroanilide, salicylanilide, 3,5-dichlorophenol and tetrachlorohydrochinone is described. Glycosidations follow the procedures described by Latham et al. Sabalitschka and Helferich et al. These glycosides represent relatively untoxic transport-forms of drugs, which are activated to the free drug by specific enzymes of the organisms to be destroyed. This new mechanisms can help to destroy fungi and parasites in dermatology, agriculture, horticulture and cultivation of decorative plants without side effects on the host.


Asunto(s)
Antiinfecciosos/síntesis química , Glicósidos/síntesis química , Salicilatos/síntesis química , Fenómenos Químicos , Química , Portadores de Fármacos , Activación Enzimática , Glicósidos/farmacología , Salicilatos/farmacología
20.
Arch Geschwulstforsch ; 50(2): 125-31, 1980.
Artículo en Alemán | MEDLINE | ID: mdl-7002089

RESUMEN

In a reveiw article the origin, the present position, and the possibilities of further development of tumour chemotherapy are described. The central problems in preparing new substances and combinations with more selective activity, and different forms of carriers with promising perspectives are discussed.


Asunto(s)
Antineoplásicos , Neoplasias/tratamiento farmacológico , Antineoplásicos/historia , Antineoplásicos Fitogénicos , Química , Quimioterapia Combinada/tendencias , Historia del Siglo XX , Humanos , Vehículos Farmacéuticos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA